BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding BioCardia, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 18 | 21 | +3 |
| Shares | 686.6K | 1.33M | +646.8K (+94.2%) |
| Value | $831.1K | $1.65M | +$815.9K (+98.2%) |
New holders (8)
Institutions that held BioCardia, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 397,594 | $493.0K | 0.00% |
| UBS Group AG | 77,619 | $96.2K | 0.00% |
| StoneX Group Inc. | 20,020 | $24.8K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 18,500 | $16.9K | 0.00% |
| Gsa Capital Partners LLP | 12,862 | $16.0K | 0.00% |
| Allied Private Wealth LLC | 1,449 | $1.40K | 0.00% |
| Global Retirement Partners, LLC | 411 | $510 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held BioCardia, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| XTX Topco Ltd | 24,270 | $29.4K |
| Virtu Financial LLC | 20,355 | $25.0K |
| Two Sigma Securities, LLC | 14,780 | $17.9K |
| Renaissance Technologies LLC | 13,900 | $16.8K |
| Vanguard Global Advisers, LLC | 268 | $324 |